Adam Feldman, MD, MPH

Adam Feldman, MD, MPH, of Massachusetts General Hospital

Articles by Adam Feldman, MD, MPH

Katie S. Murray, DO, MSUrothelial Carcinoma | June 9, 2024
The panel offers concluding thoughts on selection criteria for lymph node dissection in patients with low-grade UTUC.
View More
Katie S. Murray, DO, MSUrothelial Carcinoma | June 9, 2024
The panel dissects a longitudinal follow-up of a multicenter study of UGN-101 as well as other 2024 AUA meeting data.
Katie S. Murray, DO, MSUrothelial Carcinoma | June 9, 2024
The panel considers how to best treat patients with low-grade UTUC who experience disease recurrence post-surgery.
Katie S. Murray, DO, MSUrothelial Carcinoma | June 9, 2024
The panel highlights nephron-sparing approaches as well as current treatment pathways for low-grade UTUC.
Katie S. Murray, DO, MSUrothelial Carcinoma | June 9, 2024
The panel provides a disease state overview of low-grade UTUC, including considerations for diagnosis, staging, and grading.
Katie S. Murray, DO, MSUrothelial Carcinoma | June 9, 2024
The panel engages in a discussion related to risk stratification in UTUC, including identification of high-risk patients.